Ep. 7: Defining Pharmacologic Treatment Failure in Patients with OAB and Subsequent Treatment Strategies


Experts outline their clinical approach to identifying treatment failure in patients on initial pharmacologic treatment for OAB and strategies for subsequent treatment selection.

Please see full Prescribing Information for onabotulinumtoxinA, including Boxed Warning.

Sponsored by AbbVie US Medical Affairs

This content is intended for US/PR Healthcare Professionals.

The Medical Affairs department of AbbVie Inc. is the sole author and copyright owner of this presentation and has paid Urology Times to host this presentation. AbbVie is solely responsible for all written and oral content within this presentation. © 2023 AbbVie Inc. All rights reserved.

Related Videos
Expert on OAB
Experts on OAB
Expert on OAB
Expert on OAB
Expert on OAB
Experts on OAB
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Woman talking with doctor | Image Credit: © s_l - stock.adobe.com
Dr. Heesakkers in an interview with Urology Times
Related Content
© 2023 MJH Life Sciences

All rights reserved.